Radioiodine therapy in patient of differentiated thyroid cancer with end-stage renal disease on maintenance hemodialysis: case report with review of literature.

Abstract

Surgical resection followed by radioactive-iodine (¹³¹I) therapy constitutes a standard treatment for differentiated thyroid cancer (DTC). ¹³¹I is normally excreted through kidneys and treatment of patients with end stage renal disease (ESRD) on hemodialysis requires special attention for dosage of ¹³¹I, timing of dialysis and radiation safety. We present a case of a post-thyroidectomy patient with ESRD on haemodialysis who required radioactive iodine ablation with review of literature.